Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. - Wikidata - wikimedia - TriplyDB

Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.

Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.

http://www.wikidata.org/entity/Q44582560

about

Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway The behavioral pharmacology of hallucinogens Adenosine A(1) receptor-mediated transactivation of the EGF receptor produces a neuroprotective effect on cortical neurons in vitro p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor.Enhanced hypothalamic leptin signaling in mice lacking dopamine D2 receptors.Dopamine receptors in human adipocytes: expression and functions Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses EGFR signaling promotes TGFβ-dependent renal fibrosis Targeting Dopamine in Acute Traumatic Brain Injury Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway.Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.Sperm epidermal growth factor receptor (EGFR) mediates α7 acetylcholine receptor (AChR) activation to promote fertilization.A Selective Role for Lmo4 in Cue-Reward Learning.Receptor-Heteromer Investigation Technology and its application using BRET Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function.Catecholaminergic based therapies for functional recovery after TBI Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet.Role and regulation of EGFR in actin remodeling in sperm capacitation and the acrosome reaction "Soldier's Heart": A Genetic Basis for Elevated Cardiovascular Disease Risk Associated with Post-traumatic Stress Disorder.Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.Cellular functions regulated by phosphorylation of EGFR on Tyr845.α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.Transactivation of PDGFRbeta by dopamine D4 receptor does not require PDGFRbeta dimerization.D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways.Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress.Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.The presence and function of dopamine type 2 receptors in boar sperm: a possible role for dopamine in viability, capacitation, and modulation of sperm motility.The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.Biphasic Regulation of Caveolin-1 Gene Expression by Fluoxetine in Astrocytes: Opposite Effects of PI3K/AKT and MAPK/ERK Signaling Pathways on c-fos.Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats.Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors.Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner

P2860

Q24300160-5BF3CAC5-708A-4FDE-B751-CE465D18A20D Q24645656-0F50A596-C1AF-49AA-8CA5-EC37CD7C40BF Q28577703-7682F135-BB90-4437-A532-3EB2D9C20E7F Q28579903-1924C844-69AC-4433-9CB0-ACF0531FDCF6 Q28591542-5C6273F5-71A4-4147-8D19-80215BFB19AE Q30424531-4E3849B0-3286-4CF3-B122-DB9B630FC90D Q30435176-343316B8-48B4-424C-B7E6-542047CE2F8C Q33726520-704C7AF6-D2CB-4A52-8CFA-0A9C1CC3AE4E Q34038390-2151F567-A9A5-4DF6-87BA-67A4A33DE5F2 Q35674485-5152FC38-2CB2-4D12-9686-F5B609677A45 Q35715849-A6950C4E-FF5C-4F0C-9EAA-513C254C1E8D Q35720254-B45A2CF9-5CBC-4F76-82DE-4EA4C569AADF Q35807271-7EC5762C-4D5A-4D8B-8BD2-A8CC702E278D Q36020776-1F379438-535D-4CC8-A8E4-E9CB627B518E Q36052560-D77C83B5-016D-4F90-B7BA-6DFBC44F59A9 Q36109299-6C58E409-BB3C-48F1-A799-7637F726721F Q36180059-A264F354-4A2C-461D-B9BD-8EB17FCFF475 Q36480352-80F10E7C-A321-43DF-AF3E-28C4BF44BE47 Q36909436-A150F446-99C1-4768-82DE-D89DDC70C3A6 Q37050350-9149A40D-A4F6-4352-91DF-40B145713DBC Q37084795-D2D91050-BCC8-40AC-8C06-7E91EAC1A5F7 Q37277382-F379D3BA-1C87-4D1E-A654-3274B5397185 Q37416273-A846C815-BC58-4FB2-9F4D-1B9782C1D8A5 Q37633791-5565E032-B656-402E-ABFD-E96CDEF2C766 Q38109021-6C040664-BD2D-4719-A5E9-FA32BD562E3F Q39279185-A2743DC9-FC91-4597-8439-BE77D83C959B Q39675890-4293B686-8DBD-48EC-A378-F2EBCEF1D043 Q40017852-F6850864-4F34-4687-9BD9-6C75520C2B6F Q40416265-C0B8EE0D-4EC3-4F97-885D-27BB666F16CB Q40567929-A307B35E-D54E-466F-AA66-C6D22927DA80 Q43913445-DBF48E9C-C8DF-496C-A0CD-9975708D4CC6 Q46202653-E1823102-D7E1-4A80-A723-415EF13752DC Q46689005-93FEA368-4C52-41F8-BF69-30EF9C16389C Q47152588-93B06AFF-4E1C-4F32-93C0-2861C6A2CA98 Q51471465-337B2569-A98C-4069-B1D7-D826CE97C335 Q51739855-8F7BF6D4-9A68-4651-8A5C-5C3335D56534 Q59131861-7CB7EC97-D116-4CB9-880F-89832AACCE37

P2860

Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.

http://www.wikidata.org/entity/Q44582560

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Agonist-specific transactivati ...... d by the dopamine D2 receptor.

@en

Agonist-specific transactivati ...... d by the dopamine D2 receptor.

@nl

type

label

Agonist-specific transactivati ...... d by the dopamine D2 receptor.

@en

Agonist-specific transactivati ...... d by the dopamine D2 receptor.

@nl

prefLabel

Agonist-specific transactivati ...... d by the dopamine D2 receptor.

@en

Agonist-specific transactivati ...... d by the dopamine D2 receptor.

@nl

P1433

Q44582560-0D9AF260-174F-4B45-8A9A-7633E0814A93

P1476

Q44582560-1BB05824-BA10-4993-9D4C-2E74505DF43E

P2093

Q44582560-4DD418B8-4F7B-46A5-A30A-241E807AEB7E

Q44582560-A8E54C7E-0A54-4DCB-A9B4-9FA5BCB6111E

P2860

Q44582560-02914003-35E9-43CD-AB21-6865D3956515

Q44582560-086EAC6D-87D1-481A-B2DF-2ACB0EDD1820

Q44582560-0A23C414-82A2-4ED3-A70B-46F716B54D84

Q44582560-12560C7A-946D-4A61-A1B7-4681A37A5E51

Q44582560-1D3CF904-05A0-477C-BF56-893F5910E9AC

Q44582560-37CF3C85-1A18-46E9-8952-B3BD47F99E08

Q44582560-4BB1952F-B18E-4DF2-B1E3-CB1E84B29570

Q44582560-4C2F38D3-632C-4BC0-A7BE-F715542F4301

Q44582560-4D9F5CAF-5BC7-4726-8D08-EF2A9812678E

Q44582560-504DF3A6-C939-48DB-8E66-4C01DB9B4B4B

P304

Q44582560-B8A51E5B-CC7D-4C10-9869-5811AA44BED5

P31

Q44582560-A5F43BA7-48EE-41AA-9AA2-BAD5EBA537A7

P356

Q44582560-BBD95374-6437-44F5-80A4-E4D87EC1A0C8

P407

Q44582560-FC71A173-07EB-46A1-8777-14C7321FFAC4

P433

Q44582560-7D177841-951F-490B-97DA-2717547B4A7A

P478

Q44582560-412477AB-A2D8-4E16-A606-3830D15A636B

P577

Q44582560-15AA2891-FDE9-4335-9C56-22E7429C213F

P698

Q44582560-50A1285D-79CE-4F8B-AD77-738EF0AF1CE9

P921

Q44582560-7e5e2da3-c35a-40d6-ba98-0e668c19543d

P356

P1433

Journal of Biological Chemistry

P1476

Agonist-specific transactivati ...... d by the dopamine D2 receptor.

@en

P2093

Stuart C Sealfon

http://www.w3.org/2001/XMLSchema#string

Venugopalan D Nair

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor

AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation

Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation

Oxidants, antioxidants, and the degenerative diseases of aging

Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B

SH3 ligands in the dopamine D3 receptor

Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate

Specificity and mechanism of action of some commonly used protein kinase inhibitors

Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade

P304

47053-47061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M303364200

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

278

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12970364

http://www.w3.org/2001/XMLSchema#string

P921